![]() |
市場調查報告書
商品編碼
1830984
腎臟透析設備市場Kidney Dialysis Equipment Market |
2024 年腎臟透析設備市場價值為 168.8 億美元,預計到 2031 年將達到 267.9 億美元,2025-2031 年期間的複合年成長率預計為 6.2%。
市場洞察與分析師觀點:腎臟透析設備市場的預測是基於從各種二手和一手研究來源收集的洞察,包括主要公司出版物、協會資料和資料庫。
腎臟透析設備對於治療慢性腎臟病患者至關重要。這類設備包括透析器,當腎臟無法正常運作時,它可以過濾血液中的廢物和多餘的液體。慢性腎臟病 (CKD) 發病率的上升、需要透析治療的老年人口的增加以及已開發國家醫療報銷額的提高,正在推動腎透析設備的需求。然而,高昂的設備成本和嚴格的監管要求阻礙了腎臟透析設備市場的成長。
影響腎透析設備市場的促進因素和限制近年來,腎衰竭已成為主要死亡原因之一。根據 2022 年 4 月 ScienceDirect 發表的一篇文章,CKD 是一種進行性疾病,影響全球超過 10% 的人口,相當於超過 8 億人。隨著年齡的成長,人們因高血壓和糖尿病等與年齡相關的問題而更容易患腎臟病。透析是一種重要的治療方法,當腎臟無法有效運作時,它可以從血液中清除多餘的液體和廢物。透析設備對於管理腎功能受損的患者是必不可少的。隨著人口老化的加劇和 CKD 或末期腎病 (ESRD) 患者數量的增加,預計對血液透析機、透析器和透析濃縮液等透析設備的需求將大幅增加。因此,受高血壓、肥胖、糖尿病和人口老化等因素的影響,CKD 盛行率的上升將支持 2022 年至 2030 年腎臟透析設備市場的成長。
新興市場趨勢:機械設計和技術的創新使製造商能夠打造先進且有效率的透析設備。最新產品可提高患者舒適度、改善治療效果並縮短治療時間。透析設備中融入的滅菌技術、一次性透析器和改良的水淨化系統,可最大限度地降低感染風險。此外,居家透析治療的趨勢日益成長,這增加了對攜帶式和穿戴式透析機的需求。越來越多的數位科技公司正在進入醫療保健領域,以增強透析設備的可及性,尤其是在遠距腎臟病治療方面。例如,2023年6月,AWAK Technologies與新加坡中央醫院(SGH)合作,啟動了一項自動化穿戴式人工腎臟腹膜透析(AWAK PD)設備的關鍵性前臨床試驗。該設備是一個攜帶式系統,可讓醫療保健提供者在家中或首選地點為末期腎臟病患者提供透析服務。 2021年3月,費森尤斯醫療北美公司(FMCNA)與DaVita Kidney Care擴大合作,在美國提供家庭透析解決方案,包括NxStage家庭血液透析(HHD)機、透析耗材和互聯健康平台,旨在讓更多慢性腎衰竭患者選擇家庭透析,從而提高他們的生活品質。
因此,這些現代透析技術預計將在未來幾年為腎臟透析設備市場帶來新的趨勢。
策略洞察報告細分和範圍:「腎臟透析設備市場分析」考慮了以下細分市場:產品和最終用戶。根據產品類型,市場分為血液透析和腹膜透析設備。根據最終用戶,市場分為中心透析環境和家庭護理環境。
細分分析:就產品而言,腎臟透析設備市場分為血液透析設備及腹膜透析設備。血液透析設備細分市場在2022年佔據了更大的市場佔有率,預計在2022年至2030年期間將呈現更高的複合年成長率。血液透析是一種過濾血液中廢物和多餘液體的醫療程序,有助於調節血壓並維持鈉、鉀和鈣等必需礦物質的平衡。血液透析設備透過透析器過濾血液,該透析器的功能類似於人工腎臟,並配備內建安全功能,以確保透析過程的安全性和有效性。
依最終用戶分類,市場分為中心透析設備和家庭護理設備。 2022年,中心透析設備在腎臟透析設備市場中佔據較大佔有率,預計2022年至2030年期間的複合年成長率將更高。
區域展望:腎臟透析設備市場報告的地理範圍包括北美(美國、加拿大和墨西哥)、歐洲(西班牙、英國、德國、法國、義大利和歐洲其他地區)、亞太地區(韓國、中國、印度、日本、澳洲和亞太其他地區)、中東和非洲(南非、沙烏地阿拉伯、阿拉伯聯合大公國和中東和其他地區)以及南美洲和中美洲(巴西、阿根廷和南美洲(巴西、阿根廷和南美洲)中美洲(巴西、阿根廷和南美洲)。預計在預測期內,亞太地區將在腎臟透析設備市場中實現最快的複合年成長率。
2022 年,北美佔據了腎臟透析設備市場的最大佔有率,其中美國領先於該地區市場,其次是加拿大,原因是該地區 CKD 的盛行率不斷上升。根據美國國家糖尿病、消化和腎臟疾病衛生研究所的數據,2021 年美國有超過 3,700 萬成年人患有 CKD。 2020 年,約有 808,000 名美國人患有 ESKD,其中 69% 正在接受透析,31% 接受了腎臟移植。其他促進北美腎臟透析設備市場成長的因素包括先進醫療設備的引進、醫院數量的增加、醫療支出的增加以及政府策略政策的實施。
腎臟透析設備市場報告範圍產業發展與未來機會:全球腎臟透析設備市場主要參與者採取的幾項措施如下:
2023 年 10 月,Quanta Dialysis Technologies 在 2023 年美國腎臟學會 (ASN) 腎臟週(於 11 月 2 日至 5 日在賓夕法尼亞州費城舉行)上展示了使用其 Quanta Dialysis System 進行的 Home Run 研究的真實世界證據。 2022 年 1 月,Nextkidney BV 收購了 Dialyss Pte Ltd。此次收購顯著增強了 Nextkidney 開發和商業化其攜帶式血液透析設備 Neokidney 的能力。 Neokidney 是一種緊湊、方便用戶使用、經濟高效的家用血液透析設備,每次可處理 4 公升透析液,不依賴供水和排水,方便患者隨時隨地使用。 2021 年 3 月,百特國際公司 (Baxter International Inc.) 的 Artificial Kidney 98 (AK 98) 透析機獲得美國食品藥物管理局 (FDA) 的批准,這是一款攜帶式、方便用戶使用的下一代腎臟透析設備,可用於進行血液透析治療。 2020 年 12 月,美敦力公司推出了用於兒科急診的Carpediem心腎透析機,首批系統已在美國辛辛那提兒童醫院醫療中心成功安裝。該設備適用於急性腎損傷或需要血液透析或血液濾過治療的液體超負荷患者,也可用於體重在2.5至10公斤之間的患者的連續性腎臟替代治療(CRRT)。競爭格局與重點公司:腎臟透析設備市場報告中介紹的重點公司包括百特、貝朗醫療、BD、Cantel Medical、DaVita Inc.、費森尤斯醫療、美敦力、日機裝株式會社、旭化成株式會社、泰爾茂株式會社和Nxstage Medical, Inc.。這些公司專注於開發新技術、改進現有產品並進行地理擴張以滿足日益成長的全球需求。
The kidney dialysis equipment market was valued at US$ 16.88 billion in 2024 and is projected to reach US$ 26.79 billion by 2031, with an estimated CAGR of 6.2% during the period of 2025-2031.
Market Insights and Analyst View:The forecast for the kidney dialysis equipment market is based on insights gathered from various secondary and primary research sources, including key company publications, association data, and databases.
Kidney dialysis equipment is essential for treating patients with chronic kidney diseases. This equipment includes dialyzers that filter out waste products and excess fluids from the blood when the kidneys are unable to function properly. The rising incidence of chronic kidney diseases (CKD), a growing elderly population requiring dialysis, and increased medical reimbursements in developed nations are driving the demand for kidney dialysis equipment. However, high costs of equipment and strict regulatory requirements are hindering the growth of the kidney dialysis equipment market.
Drivers and Restraints Affecting Kidney Dialysis Equipment Market
Kidney failure has become one of the leading causes of death in recent years. According to an article published in ScienceDirect in April 2022, CKD is a progressive condition affecting over 10% of the global population, which translates to more than 800 million individuals. As people age, they become more vulnerable to kidney diseases due to age-related issues like hypertension and diabetes. Dialysis is a critical treatment that removes excess fluids and waste from the blood when the kidneys cannot function effectively. Dialysis equipment is necessary for managing patients with compromised kidney function. With the increasing aging population and the rising number of CKD or end-stage renal disease (ESRD) patients, the demand for dialysis equipment such as hemodialysis machines, dialyzers, and dialysis concentrates is anticipated to grow significantly. Therefore, the rising prevalence of CKD, influenced by factors such as hypertension, obesity, diabetes, and an aging demographic, supports the growth of the kidney dialysis equipment market from 2022 to 2030.
Emerging Market Trends
Innovations in machine design and technology enable manufacturers to create advanced and efficient dialysis equipment. The latest offerings provide enhanced patient comfort, better treatment outcomes, and reduced treatment durations. The incorporation of sterilization technologies, disposable dialyzers, and improved water purification systems in dialysis equipment minimizes the risk of infections. Furthermore, there is a growing trend towards home-based dialysis treatments, increasing the demand for portable and wearable dialysis machines. More digital technology companies are entering the healthcare sector to enhance access to dialysis equipment, especially for remote renal disorder treatments. For example, in June 2023, AWAK Technologies partnered with Singapore General Hospital (SGH) to initiate a pre-pivotal clinical trial for an automated wearable artificial kidney peritoneal dialysis (AWAK PD) device. This device is a portable system that allows healthcare providers to facilitate dialysis for end-stage kidney disease patients in their homes or preferred locations. In March 2021, Fresenius Medical Care North America (FMCNA) and DaVita Kidney Care expanded their collaboration to offer home dialysis solutions in the US, including NxStage home hemodialysis (HHD) machines, dialysis supplies, and a connected health platform, aimed at empowering more chronic kidney failure patients to choose home dialysis, thereby enhancing their quality of life.
Consequently, these modern dialysis technologies are expected to introduce new trends in the kidney dialysis equipment market in the upcoming years.
Strategic Insights
Report Segmentation and Scope:The "kidney dialysis equipment market analysis" has been conducted considering the following segments: product and end user. The market is divided into hemodialysis and peritoneal dialysis equipment based on product type. By end user, the market is categorized into in-center dialysis settings and home care settings.
Segmental Analysis:In terms of product, the kidney dialysis equipment market is divided into hemodialysis equipment and peritoneal dialysis equipment. The hemodialysis equipment segment held a larger market share in 2022 and is expected to exhibit a higher CAGR from 2022 to 2030. Hemodialysis is a medical procedure that filters waste and excess fluid from the blood, helping to regulate blood pressure and maintain the balance of essential minerals such as sodium, potassium, and calcium. The hemodialysis equipment filters blood through a dialyzer that functions as an artificial kidney, equipped with built-in safety features to ensure the process's safety and effectiveness.
By end user, the market is segmented into in-center dialysis settings and home care settings. The in-center dialysis settings segment accounted for a larger share of the kidney dialysis equipment market in 2022 and is projected to experience a higher CAGR from 2022 to 2030.
Regional Outlook:The geographic scope of the kidney dialysis equipment market report includes North America (US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). The Asia Pacific region is expected to register the fastest CAGR in the kidney dialysis equipment market during the forecast period.
North America held the largest share of the kidney dialysis equipment market in 2022, with the US leading the market in this region, followed by Canada, due to the rising prevalence of CKD among the population. According to the National Health Institute of Diabetes and Digestive and Kidney Diseases, over 37 million adults in the US were affected by CKD in 2021. Approximately 808,000 Americans were living with ESKD in 2020, with 69% undergoing dialysis and 31% receiving kidney transplants. Other factors contributing to the growth of the kidney dialysis equipment market in North America include the introduction of advanced healthcare equipment, an increasing number of hospitals, rising healthcare expenditures, and the implementation of strategic government policies.
Kidney Dialysis Equipment Market Report Scope
Industry Developments and Future Opportunities:Several initiatives undertaken by key players in the global kidney dialysis equipment market are highlighted below:
In October 2023, Quanta Dialysis Technologies presented real-world evidence from its Home Run study using its Quanta Dialysis System at the American Society of Nephrology (ASN) Kidney Week 2023, held from November 2 to 5 in Philadelphia, Pennsylvania.
In January 2022, Nextkidney BV acquired Dialyss Pte Ltd. This acquisition significantly enhanced Nextkidney's ability to develop and commercialize its portable hemodialysis device-Neokidney, a compact, user-friendly, cost-effective home hemodialysis device capable of handling 4 liters of dialysate per session, independent of water supply and drainage, making it accessible to patients anytime and anywhere.In March 2021, Baxter International Inc. received clearance from the US Food and Drug Administration (FDA) for its Artificial Kidney 98 (AK 98) dialysis machine, a next-generation kidney dialysis device that is portable and user-friendly for administering hemodialysis treatments.
In December 2020, Medtronic plc launched the Carpediem Cardio-Renal Dialysis Machine for pediatric emergencies, with the first systems successfully installed in the US at Cincinnati Children's Hospital Medical Center. This machine is indicated for acute kidney injury or patients with fluid overload requiring hemodialysis or hemofiltration therapy and is also used for continuous renal replacement therapy (CRRT) for patients weighing between 2.5 and 10 kg.
Competitive Landscape and Key Companies:Key companies profiled in the kidney dialysis equipment market report include Baxter, B.Braun Medical Inc., BD, Cantel Medical, DaVita Inc., Fresenius Medical Care, Medtronic, Nikkiso Co., Ltd., Asahi Kasei Corporation, Terumo Corporation, and Nxstage Medical, Inc. These companies are focused on developing new technologies, enhancing existing products, and expanding geographically to meet the growing global demand.